Taylor Sandison
2019
In 2019, Taylor Sandison earned a total compensation of $774.1K as Chief Medical Officer at Cidara Therapeutics, a 14% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $143,500 |
|---|---|
| Option Awards | $147,786 |
| Salary | $422,000 |
| Stock Awards | $58,000 |
| Other | $2,800 |
| Total | $774,086 |
Sandison received $422K in salary, accounting for 55% of the total pay in 2019.
Sandison also received $143.5K in non-equity incentive plan, $147.8K in option awards, $58K in stock awards and $2.8K in other compensation.
Rankings
In 2019, Taylor Sandison's compensation ranked 10,359th out of 13,971 executives tracked by ExecPay. In other words, Sandison earned more than 25.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,359 out of 13,971 | 26th |
Division Manufacturing | 4,193 out of 5,701 | 27th |
Major group Chemicals And Allied Products | 1,614 out of 2,200 | 27th |
Industry group Drugs | 1,383 out of 1,886 | 27th |
Industry Biological Products, Except Diagnostic Substances | 306 out of 389 | 21st |
Source: SEC filing on April 29, 2020.
Sandison's colleagues
We found two more compensation records of executives who worked with Taylor Sandison at Cidara Therapeutics in 2019.
News
Cidara Therapeutics CEO Jeffrey Stein's 2023 pay jumps 24% to $1.6M
June 3, 2024
Cidara Therapeutics CEO Jeffrey Stein's 2022 pay falls 23% to $1.3M
April 27, 2023
Cidara Therapeutics CEO Jeffrey Stein's 2021 pay jumps 26% to $1.6M
April 29, 2022
Cidara Therapeutics CEO Jeffrey Stein's 2019 pay rises 6% to $1.5M
April 29, 2020
Cidara Therapeutics CEO Jeffrey Stein's 2018 pay falls 25% to $1.4M
April 26, 2019